4d Molecular Therapeutics In shares owned by Credit Suisse
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $452k | 22k | 20.26 |
| 2023-09-30 | $328k | 26k | 12.73 |
| 2023-06-30 | $626k | 35k | 18.07 |
| 2023-03-31 | $232k | 14k | 17.19 |
| 2022-12-31 | $22 | 1 | 22.00 |
| 2022-09-30 | $139k | 18k | 7.92 |
| 2022-06-30 | $124k | 17k | 7.13 |
| 2022-03-31 | $281k | 19k | 15.05 |
| 2021-12-31 | $324k | 15k | 21.67 |
| 2021-09-30 | $231k | 8.9k | 25.84 |